
The paradox of market restriction for anti-TB drugs Premium
The Hindu
Newer anti-TB drugs like Bedaquiline, Delamanid, and Pretomanid may be restricted to NTEP, impacting TB treatment accessibility.
More Related News

Newer anti-TB drugs like Bedaquiline, Delamanid, and Pretomanid may be restricted to NTEP, impacting TB treatment accessibility.